Cross Country Healthcare (CCRN) Tops Q2 EPS by 7c, Q3 Guidance Beats

Cross Country Healthcare (NASDAQ: CCRN) reported Q2 EPS of $0.47, $0.07 better than the analyst estimate of $0.40. Revenue for the quarter came in at $331.83 million versus the consensus estimate of $297.34 million.

GUIDANCE:

Cross Country Healthcare sees Q3 2021 EPS of $0.30-$0.35, versus the consensus of $0.22. Cross Country Healthcare sees Q3 2021 revenue of $310-320 million, versus the consensus of $253.3 million.

For earnings history and earnings-related data on Cross Country Healthcare (CCRN) click here.

You May Also Be Interested In

• Kroger (KR) Reports In-Line Q1 EPS, Beats on Revenue; Offers FY27 EPS Guidance
• Jabil (JBL) Tops Q3 EPS by 8c, Offers Guidance
• FedEx (FDX) PT Lowered to $424 at Bernstein SocGen Group